No abstract available.
Abscess*

No abstract available.
Child* ; Humans ; Lung*

Although lymphoma may involve any part of gastrointestinal tract either primary or secondary, esophageal involvement is rare. Secondary esopahgeal involvement of lymphoma is showing an incidence between 0% and 6% with autopsy series and lesser then 1% in living patients. The occurrence of a tracheoesophageal fistula(TEF) in patient with lymphoma is even more rare. We describe one case of TEF due to secondary esophageal invasion of T-cell lympboma and review the literature, with particular attention to chest CT and esophagoscopic finding, and endoscopic biopsy result.
Autopsy ; Biopsy ; Gastrointestinal Tract ; Humans ; Incidence ; Lymphoma ; Lymphoma, T-Cell* ; T-Lymphocytes* ; Tomography, X-Ray Computed ; Tracheoesophageal Fistula*

Blueberry muffin rashes occur in various diseases including TORCH syndrome, transfusion reactions, leukemia, hereditary spherocytosis and neonatal sepsis. We report a case of congenital CMV(cytomegalovirus) infection showing blueberry muffin skin lesions which revealed dermal erythropoiesis. Even though these cutaneous findings were nonspecific, they could provide a valuable clue in approach the congenital viral infection in the perinatal period.
Blueberry Plant ; Erythropoiesis* ; Exanthema ; Leukemia ; Sepsis ; Skin* ; Transfusion Reaction

From 1985 to 1995, 13 children with neurogenic bladder underwent augmentation cystoplasty. Diagnosis in these 13 children included Meningomyelocele in 11 and unknown origin in 2. Indications for augmentation cystoplasty were persists incontinence in 6 patients and progressive upper urinary tract deterioration in Bowel segments were used for augmentation included sigmoid colon in 1 patient, ileocecal segments incontinence in 6 patients stomach in 3. Dilated ureter also was used in 1 patient. Postoperatively, all the patients have stable upper tracts radiographically and stable or improved renal function. Of 13 patients 12 require clean intermittent catheterization to empty bladder and 10 are completely continent. After operation, bladder capacity increased from 155 ml to 305 ml and there were significant increases in bladder compliance. Hypereflexia was present in 5 patients before operation and in 3 patients after operation. There has been no surgical mortality. Postoperative complications occurred in 4 patients included mild ileus in 2 patients, mucus obstruction in 1, mild hematuria in 1, metabolic alkalosis in 1 and superficial wound infection in All complications were transient and managed medically. the kind of bowel segments did not seem to influence results. We think that augmentation cystoplasty is a therapeutic modality that should be considered as a viable treatment option in selected patients with neurogenic bladder dysfunction.
Alkalosis ; Child ; Colon, Sigmoid ; Compliance ; Diagnosis ; Hematuria ; Humans ; Ileus ; Intermittent Urethral Catheterization ; Meningomyelocele ; Mortality ; Mucus ; Postoperative Complications ; Stomach ; Ureter ; Urinary Bladder ; Urinary Bladder, Neurogenic* ; Urinary Tract ; Wound Infection

Audiant bone conductor(ABC) can be beneficial to patients with conductive hearing loss and sensorineural hearing loss. We have implanted ABC for 3 patients with bilateral conductive hearing loss and 2 patients with unilateral profound sensorineural hearing loss. And we evaluated the hearing gain in these patients except 1 case who did not return for follow up. The preoperative average air conduction threshoulds at the three speech frequencies 500, 1000 and 2000Hz, SRT, SD scores were 48.3dB HL, 47.5dB HL, 95% respectively and 19.1dB HL, 20dB HL, 95% postoperatively in 2 patients with bilateral conductive hearing loss. The preoperative average air conduction threshoulds at the three speech frequencies 500, 1000 and 2000Hz, SRT, SD scores were no response, no response, 0% respectively and 42.5dB HL, 51.3dB HL, 60% postoperatively in 2 patients with sensorineural hearing loss.
Follow-Up Studies ; Hearing ; Hearing Loss, Conductive ; Hearing Loss, Sensorineural ; Humans

BACKGROUND: Patient-controlled analgesia (PCA) provides excellent pain relief in the management of postoperative pain, but is associated with unpleasant side effects such as nausea and vomiting. The transdermal scopolamine patch (TSP) has been shown to have effective antiemetic actions. We evaluated the effectiveness of TSP in patients receiving morphine and fentanyl via intravenous PCA. METHODS: Sixty patients were scheduled for an elective intra-abdominal gynecologic surgery under general anesthesia, and had elected to receive intravenous PCA postoperatively. Soon after their arrival in the operating room, the patients were randomised to receive either a placebo patch (group P) or TSP (group S) on the right postauricular area. Nausea, vomiting and sedation were scored at the postoperative care unit (PACU) and at 12, 24, 48, and 72 h postoperatively. Patients were treated with metoclopramide as deemed necessary by the primary care nurse. RESULTS: No differences were found between the groups in scores and incidence of nausea and vomiting at the PACU and at 12, 24, 48, and 72 h postoperatively. The patients who received metoclopramide were significantly fewer in group S than in group P (6.7% vs 43.3%, P < 0.05). The sedation score was significantly lower in group S than in group P (1.3 0.5 vs 1.8 0.9, P < 0.05) at 12h postoperatively. CONCLUSIONS: TSP did not reduce the incidence and score of nausea and vomiting in postoperative patients during intravenous PCA. However, patients who received TSP required less antiemetic medication. TSP appears to be effective for supplemental antiemetic medication.
Analgesia, Patient-Controlled* ; Anesthesia, General ; Female ; Fentanyl ; Gynecologic Surgical Procedures ; Humans ; Incidence ; Metoclopramide ; Morphine ; Nausea ; Operating Rooms ; Pain, Postoperative ; Passive Cutaneous Anaphylaxis ; Postoperative Care ; Postoperative Nausea and Vomiting* ; Primary Health Care ; Scopolamine Hydrobromide* ; Vomiting

BACKGROUND: Patient-controlled analgesia (PCA) provides excellent pain relief in the management of postoperative pain, but is associated with unpleasant side effects such as nausea and vomiting. The transdermal scopolamine patch (TSP) has been shown to have effective antiemetic actions. We evaluated the effectiveness of TSP in patients receiving morphine and fentanyl via intravenous PCA. METHODS: Sixty patients were scheduled for an elective intra-abdominal gynecologic surgery under general anesthesia, and had elected to receive intravenous PCA postoperatively. Soon after their arrival in the operating room, the patients were randomised to receive either a placebo patch (group P) or TSP (group S) on the right postauricular area. Nausea, vomiting and sedation were scored at the postoperative care unit (PACU) and at 12, 24, 48, and 72 h postoperatively. Patients were treated with metoclopramide as deemed necessary by the primary care nurse. RESULTS: No differences were found between the groups in scores and incidence of nausea and vomiting at the PACU and at 12, 24, 48, and 72 h postoperatively. The patients who received metoclopramide were significantly fewer in group S than in group P (6.7% vs 43.3%, P < 0.05). The sedation score was significantly lower in group S than in group P (1.3 0.5 vs 1.8 0.9, P < 0.05) at 12h postoperatively. CONCLUSIONS: TSP did not reduce the incidence and score of nausea and vomiting in postoperative patients during intravenous PCA. However, patients who received TSP required less antiemetic medication. TSP appears to be effective for supplemental antiemetic medication.
Analgesia, Patient-Controlled* ; Anesthesia, General ; Female ; Fentanyl ; Gynecologic Surgical Procedures ; Humans ; Incidence ; Metoclopramide ; Morphine ; Nausea ; Operating Rooms ; Pain, Postoperative ; Passive Cutaneous Anaphylaxis ; Postoperative Care ; Postoperative Nausea and Vomiting* ; Primary Health Care ; Scopolamine Hydrobromide* ; Vomiting

BACKGROUND: Benign prostatic hyperplasia (BPH) is the most common benign tumor in older men; the etiology of this disease remains poorly understood. Testosterone and dihydrotestosterone (DHT) both act as androgen via a single androgen receptor. Testosterone is converted to DHT by 5alpha-reductase in prostatic stromal cells. Progesterone has been reported to inhibit DHT conversion; howevwe, its effect on prostatic stromal cells remains to be elucidated. MATERILAS AND METHODS: In this experiment, we investigated the effect of progesterone on androgen receptor expression induced by DHT. We also tested the effect of progesterone on cyclooxygenase-2 (COX-2) expression, as well as prostate stromal cell proliferation using the cell count kit-8. RESULTS: Progesterone did not cause an increase of prostate stromal cell proliferation. The mRNA expression of the androgen receptor and COX-2 were not changed by progesterone; the expressions of androgen receptor and COX-2 proteins were decreased by progesterone in prostate stromal cells. CONCLUSION: These results suggest that in prostate stromal cells, progesterone decreases androgen receptor protein expression, which results in decrement of COX-2 protein expression. This effect might be mediated by post-transcriptional regulation.
Cell Count ; Cyclooxygenase 2 ; Dihydrotestosterone ; Humans ; Male ; Progesterone* ; Prostate* ; Prostatic Hyperplasia ; Receptors, Androgen ; RNA, Messenger ; Stromal Cells* ; Testosterone